LEADER 01497nam  2200493 a 450 
001 9910791483303321
005 20200520144314.0
010   $a1-61728-173-5
035   $a(CKB)2560000000015765
035   $a(SSID)ssj0000413706
035   $a(PQKBManifestationID)12137337
035   $a(PQKBTitleCode)TC0000413706
035   $a(PQKBWorkID)10399426
035   $a(PQKB)11118663
035   $a(MiAaPQ)EBC3020128
035   $a(Au-PeEL)EBL3020128
035   $a(CaPaEBR)ebr10675136
035   $a(OCoLC)923662897
035   $a(EXLCZ)992560000000015765
100   $a20091007d2009      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aCellular senescence$b[electronic resource] $eimplications for cancer therapy /$fRazmik Mirzayans and David Murray
210   $aNew York $cNova Biomedical Books$dc2009
215   $a113 p. $cill. (some col.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-60692-676-4 
320   $aIncludes bibliographical references (p. [75]-100) and index.
606   $aCells$xAging
606   $aCancer$xTreatment
615  0$aCells$xAging.
615  0$aCancer$xTreatment.
700   $aMirzayans$b Razmik$01526063
701   $aMurray$b David$cPh. D.$0112250
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910791483303321
996   $aCellular senescence$93767886
997   $aUNINA